Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of Immunology

• Publication date

  1981-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.127.2.665PMID 7019328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen‐Reactive Cell Opsonization (ARCO) and its Role in Antibody‐Mediated Immune Suppression

  1980cited by this paper
• Suppression of Rejection of Organ Allografts by Alloantibody *

  1980cited by this paper
• A QUANTITATIVE COMPARISON OF WHOLE ANTIBODY AND F(ab)2 IN KIDNEY ALLOGRAFT ENHANCEMENT1

  1979cited by this paper
• Opsonization of alloreactive Ly-1+ T cells by antigen-antibody complexes containing free I-A determinants.

  1979cited by this paper
• Selective suppression of humoral and cell-mediated immune responses to rat alloantigens by monoclonal antibodies produced by hybridoma cell lines.

  1979cited by this paper
• Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.

  1979cited by this paper
• Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.

  1979cited by this paper
• A sensitive haemolytic assay of mouse complement.

  1978cited by this paper
• The role of complement factors in acute antibody‐mediated rejection of mouse skin allografts

  1978cited by this paper
• Antibody response and skin graft rejection in the nude mouse.

  1977cited by this paper
• Cytotoxic versus immunoblocking effects of specific alloantibodies: effects of IgM, IgG, and IgG2 on rat kidney allograft survival.

  1977cited by this paper
• ANTIGEN‐REACTIVE CELL OPSONIZATION (ARCO): A MECHANISM OF IMMUNOLOGICAL ENHANCEMENT

  1977cited by this paper
• Opsonic activity of "anti-Ia"-like enhancing antisera.

  1977cited by this paper
• Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.

  1977cited by this paper
• Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

  1976cited by this paper
• Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.

  1976cited by this paper
• COMPLEMENT ORIGIN DETERMINES LYTIC ACTIVITY OF ANTIBODIES TO NUCLEATED TARGET CELLS: COMPARISON OF COMMON COMPLEMENT SOURCES

  1976cited by this paper
• IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.

  1975cited by this paper
• MODIFICATION OF THE RAT ALLOIMMUNE RESPONSE BY ENHANCING ANTIBODIES AND THE ROLE OF BLOCKING FACTORS IN THE SURVIVAL OF RENAL GRAFTS

  1975cited by this paper
• Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.

  1975cited by this paper
• The use of indirect immunofluorescence to evaluate the gel filtration method of fractionating human immunoglobulins.

  1975cited by this paper
• Biologic properties of transplantation immune sera. IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes.

  1975cited by this paper
• Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).

  1975cited by this paper
• Modification by passive IgM of the immune response of mice to a tumor allograft.

  1974cited by this paper
• Suppression and enhancement of allografted tumour.

  1974cited by this paper
• QUANTITATIVE STUDIES ON TUMOR ENHANCEMENT IN MICE

  1974cited by this paper
• Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.

  1973cited by this paper
• Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.

  1973cited by this paper
• Phagocytic cells as effectors in a cell-mediated immunity system.

  1973cited by this paper
• Immunological enhancement of skin grafts in the mouse.

  1972cited by this paper
• BIOLOGICAL PROPERTIES OF ANTIBODY CLASSES IN TRANSPLANTATION IMMUNE SERA

  1969cited by this paper
• COMPETITION OF 19S AND 7S ANTIGEN RECEPTORS IN THE REGULATION OF THE PRIMARY IMMUNE RESPONSE

  1968cited by this paper
• Inhancement activity of mouse immunoglobulin classes.

  1967cited by this paper
• Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system.

  1966cited by this paper
• ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL

  1965cited by this paper
• Specific Inhibition of Antibody Formation by Passively Administered 19S and 7S Antibody

  1964cited by this paper

• Half a century of Dutch transplant immunology.

  2014cites this paper
• Effector mechanisms in transplant rejection

  2003cites this paper
• The role of adaptation in allograft acceptance.

  1989cites this paper
• Renal Transplantation: Sense and Sensitization

  1988cites this paper
• Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.

  1987cites this paper
• LONG‐TERM PASSIVE ENHANCEMENT OF ALLOGENEIC SKIN GRAFTS WITH MONOCLONAL ANTIBODIES

  1985cites this paper
• Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.

  1984cites this paper
• Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.

  1983cites this paper
• Effect of decomplementation with cobra venom factor on the passive immunological enhancement of mouse skin allografts.

  1982cites this paper